(Press-News.org) Use of a patient's bone marrow cells for treating chronic ischemic heart failure did not result in improvement on most measures of heart function, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the American College of Cardiology's annual scientific sessions.
Cell therapy has emerged as an innovative approach for treating patients with advanced ischemic heart disease, including those with heart failure. "In patients with ischemic heart disease and heart failure, treatment with autologous [derived from the same individual] bone marrow mononuclear cells (BMCs) has demonstrated safety and has suggested efficacy. None of the clinical trials performed to date, however, have been powered to evaluate specific efficacy measures," according to background information in the article.
Emerson C. Perin, M.D., Ph.D., of the Texas Heart Institute and St. Luke's Episcopal Hospital, Houston and colleagues conducted a study to examine the effect of transendocardial administration (use of a special catheter and injection procedure to deliver stem cells to the heart muscle) of BMCs to patients with chronic ischemic heart disease and left ventricular (LV) dysfunction with heart failure and/or angina. The patients in the phase 2 randomized trial were receiving maximal medical therapy at 5 National Heart, Lung, and Blood Institute–sponsored Cardiovascular Cell Therapy Research Network (CCTRN) sites between April 2009 and April 2011. Patients were randomized to receive transendocardial injection of BMCs or placebo. The primary outcomes measured for the study, assessed at 6 months, were changes in left ventricular end-systolic volume (LVESV) assessed by echocardiography, maximal oxygen consumption, and reversibility of perfusion (blood flow) defect on single-photon emission tomography (SPECT). Of 153 patients who provided consent, a total of 92 (82 men; average age: 63 years) were randomized (n = 61 in BMC group and n = 31 in placebo group).
Analysis of data indicated no statistically significant differences between the groups for the primary end points of changes in LVESV index, maximal oxygen consumption, and reversible defect. There were also no differences in any of the secondary outcomes, including percent myocardial defect, total defect size, fixed defect size, regional wall motion (the movement of the wall of the heart during contraction), and clinical improvement.
In an exploratory analysis, the researchers did find that when LVEF was assessed, patients age 62 years or younger showed a statistically significant effect of therapy. Patients in the BMC group demonstrated an average increase in LVEF of 3.1 percent from baseline to 6 months, whereas patients in the placebo group showed a decrease of −1.6 percent.
"In the largest study to date of autologous BMC therapy in patients with chronic ischemic heart disease and LV dysfunction, we found no effect of therapy on prespecified end points. Further exploratory analysis showed a significant improvement in LVEF associated with treatment. Our findings provide evidence for further studies to determine the relationship between the composition and function of bone marrow product and clinical end points. Understanding these relationships will improve the design and interpretation of future studies of cardiac cell therapy," the authors write.###
(JAMA. 2012;307(16):doi:10.1001/jama.2012.418. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Study examines treatment of heart failure with bone marrow cells
2012-03-26
ELSE PRESS RELEASES FROM THIS DATE:
Cell therapy using patient's own bone marrow may present option for heart disease
2012-03-26
CHICAGO— Cell therapy may present an option for patients with ischemic heart disease to use their own bone marrow cells to repair the damaged areas of their hearts, and may pave the way for future treatment options, according to the FOCUS trial, which will be presented as a late-breaking clinical trial March 24 at the 61st annual American College of Cardiology (ACC) scientific session.
This is the largest study to date to look at stem cell therapy, using a patient's own stem cells, to repair damaged areas of the heart in patients with chronic ischemic heart disease and ...
Tears during coronary angioplasty: Where are they and how do they affect patient outcomes?
2012-03-26
CHICAGO – Researchers from Thomas Jefferson University Hospital discovered that blockages in the right coronary artery and those in bending areas of the coronary artery are the most common places for dissection, a tear in the artery that can occur during balloon angioplasty of the coronary arteries.
They will present their findings at the American College of Cardiology annual meeting in Chicago on Saturday, March 24 at 9 AM.
A 'controlled tear' is the mechanism by which angioplasty dilates the blocked vessels. A large tear, or spiral dissection, that continues ...
Popcorn: the snack with even higher antioxidant levels than fruits and vegetables
2012-03-26
SAN DIEGO, March 25, 2012 — Popcorn's reputation as a snack food that's actually good for health popped up a few notches today as scientists reported that it contains more of the healthful antioxidant substances called "polyphenols" than fruits and vegetables. They spoke at the 243rd National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society, being held here this week.
Joe Vinson, Ph.D., a pioneer in analyzing healthful components in chocolate, nuts and other common foods, explained that the polyphenols are more concentrated ...
Some scum! Microbe in pond scum enlisted in new cancer test
2012-03-26
SAN DIEGO, March 25, 2012 — Scientists are enlisting the living, self-propelled microbes found in pond scum — the pea-green surface slicks that form on ponds — in the development of a long-awaited new test to detect the cells that spread cancer through the bloodstream from the original tumor to new sites in the body.
In a report here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society, they described how the test is intended to not only identify the spreading of cells, but allow lab analysis of ...
Preserving arson evidence with triclosan
2012-03-26
SAN DIEGO, March 25, 2012 — A preservative in toothpastes, hand soaps, underarm deodorants and other everyday products is getting a second life, helping crime scene investigators preserve evidence of arson, scientists reported here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS).
The preservative, triclosan, would be the first evidence preservative for traces of gasoline and other ignitable fluids, or flame "accelerants," commonly used in arson, according to John V. Goodpaster, Ph.D., an international expert who reported on evidence ...
Nuclear power plants can produce hydrogen to fuel the 'hydrogen economy'
2012-03-26
SAN DIEGO, March 25, 2012 — The long-sought technology for enabling the fabled "hydrogen economy" — an era based on hydrogen fuel that replaces gasoline, diesel and other fossil fuels, easing concerns about foreign oil and air pollution — has been available for decades and could begin commercial production of hydrogen in this decade, a scientist reported here today.
Speaking at the 243rd National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society, Ibrahim Khamis, Ph.D., described how heat from existing nuclear plants could ...
J. Craig Venter, Ph.D., describes biofuels, vaccines and foods from made-to-order microbes
2012-03-26
SAN DIEGO, March 25, 2012 —Just as aspiring authors often read hundreds of books before starting their own, scientists are using decades of knowledge garnered from sequencing or "reading" the genetic codes of thousands of living things to now start writing new volumes in the library of life. J. Craig Venter, Ph.D., one of the most renowned of those scientists, described the construction of the first synthetic cell and many new applications of this work today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific ...
'Noodle gels' or 'spaghetti highways' could become tools of regenerative medicine
2012-03-26
SAN DIEGO, March 25, 2012 — Medicine's recipe for keeping older people active and functioning in their homes and workplaces — and healing younger people injured in catastrophic accidents — may include "noodle gels" and other lab-made invisible filaments that resemble uncooked spaghetti with nanoscale dimensions, a scientist said here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS). The world's largest scientific society, ACS is meeting here this week with reports on more than 11,000 reports on new advances in science on its schedule.
Samuel ...
American Chemical Society President unveils initiatives for 2012
2012-03-26
SAN DIEGO, March 25, 2012 — Bassam Z. Shakhashiri, Ph.D., president of the American Chemical Society (ACS) — the world's largest scientific society — today described initiatives on climate science, the education of future scientists and commemoration of a landmark federal law that engendered some of the nation's greatest universities. Those initiatives will be the theme of Shakhashiri's presidential year.
A chemistry professor who holds the William T. Evjue Distinguished Chair for the Wisconsin Idea at the University of Wisconsin-Madison, Shakhashiri discussed the projects ...
Materials inspired by Mother Nature: A 1-pound boat that could float 1,000 pounds
2012-03-26
SAN DIEGO, March 25, 2012 — Combining the secrets that enable water striders to walk on water and give wood its lightness and great strength has yielded an amazing new material so buoyant that, in everyday terms, a boat made from 1 pound of the substance could carry five kitchen refrigerators, about 1,000 pounds.
One of the lightest solid substances in the world, which is also sustainable, it was among the topics of a symposium here today at the 243rd National Meeting & Exposition of the American Chemical Society, the world's largest scientific society. The symposium ...